NASDAQ : AIMD

Ainos, Inc. — Company profile

Technology · Scientific & Technical Instruments · United States

Last price 0.6286 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.64M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women’s health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Details

NameAinos, Inc.
SectorTechnology
IndustryScientific & Technical Instruments
Employees41
Founded1984
CeoChun-Hsien Tsai
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS00902F4028
Cusip00902F402
Cik1014763
Sic3577
Stock TypeCommon Stock

Key executives

NameTitle
Chun-Hsien TsaiChief Executive Officer, President and Chairman of the Board
Hsin-Liang LeeChief Financial Officer
Chih-Heng LuDirector of Corporate Developoment

Contact

Address3050 Post Oak Boulevard, Suite 510-T80, Houston, Texas 77056, United States
Phone281 898 6586
Websitehttps://www.ainos.com